FDA Publishes Final Guidance on Physical Attributes of Generics
FDA Publishes Draft Guidances and Memorandum of Understanding on Drug Compounding and Repackaging
Major FDA Announcement on OTCs
FDA Issues Draft Guidance on Size and Shape of Generic Tablets and Capsules
FDA Denies 5-Year Exclusivity to “Stable Esters” and Confirms Structure-Based Approach to Exclusivity
Subscribe: Subscribe via RSS
Firm/Org